We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

30 hedge funds and large institutions have $18.2M invested in Global Cord Blood Corporation in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

7% more funds holding

Funds holding: 2830 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

22% less capital invested

Capital invested by funds: $23.4M → $18.2M (-$5.22M)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.87%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
8
Increased
4
Reduced
6
Closed
6
Calls
Puts
Net Calls
Net Calls Change

CO Hedge Fund Activity: Q1 2014 in Review

30 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2014, worth a combined $18.2M — down 22% from $23.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new CO positions and 6 closed out — a net gain of 2 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $2.17M. The largest seller was Starr International Company, cutting an estimated $7.5M.

  • 30 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2014, up from 28 in Q4 2013.
  • Funds reported $18.2M of Global Cord Blood Corporation stock for Q1 2014, down 22% quarter-over-quarter.
  • 8 funds opened new Global Cord Blood Corporation positions in Q1 2014 and 6 closed out, a net change of +2 holders.
  • The largest Global Cord Blood Corporation buyer in Q1 2014 was Fidelity Investments, an estimated $2.17M added.
  • The largest Global Cord Blood Corporation seller in Q1 2014 was Starr International Company, an estimated $7.5M sold.

Based on aggregated 13F filings for Q1 2014.